Live Breaking News & Updates on Alnylam Pharmaceuticals Stock Down

Stay updated with breaking news from Alnylam pharmaceuticals stock down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Insider Selling: Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Director Sells 21,700 Shares of Stock

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) Director Amy W. Schulman sold 21,700 shares of Alnylam Pharmaceuticals stock in a transaction on Wednesday, May 29th. The stock was sold at an average price of $148.60, for a total value of $3,224,620.00. Following the transaction, the director now directly owns 8,436 shares of the company’s […] ....

Amyw Schulman , Securities Exchange Commission , Allspring Global Investments Holdings , Altitude Crest Partners Inc , Alnylam Pharmaceuticals Stock Down , Alnylam Pharmaceuticals Inc , Quent Capital , Investment Management , Wells Fargo Company , Morgan Stanley , News Ratings For Alnylam Pharmaceuticals Daily , Alnylam Pharmaceuticals Company Profile , Alnylam Pharmaceuticals , Get Free Report , Director Amy , Exchange Commission , Pharmaceuticals Stock Down , Global Investments Holdings , Crest Partners , Alnylam Pharmaceuticals Daily ,

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Given Average Recommendation of "Moderate Buy" by Brokerages

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the seventeen ratings firms that are presently covering the company, Marketbeat.com reports. Seven equities research analysts have rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average 1 […] ....

New Zealand General , New Zealand , Amyw Schulman , William Blair , Capital Research Global Investors , Alnylam Pharmaceuticals Stock Down , News Ratings For Alnylam Pharmaceuticals Daily , Norges Bank , Alnylam Pharmaceuticals , Institutional Trading Of Alnylam Pharmaceuticals , Wellington Management Group , Analyst Recommendations For Alnylam Pharmaceuticals , Alnylam Pharmaceuticals Inc , Capital International Investors , Vanguard Group Inc , Insider Activity At Alnylam Pharmaceuticals , Royal Bank , Get Free Report , Chardan Capital , Director Amy , International Investors , Management Group , Research Global Investors , Pharmaceuticals Stock Down , Get Free , Alnylam Pharmaceuticals Daily ,

TD Asset Management Inc Sells 29,279 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

TD Asset Management Inc Sells 29,279 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Royal Bank , Td Asset Management Inc , Quarter For Alnylam Pharmaceuticals , Alnylam Pharmaceuticals Stock Down , Exchange Commission , Alnylam Pharmaceuticals Inc , Alnylam Pharmaceuticals , Morgan Stanley , Oxford Asset Management , Nixon Peabody Trust Co , Commerce Bank , Nomura Asset Management Co , Goldman Sachs Group , News Ratings For Alnylam Pharmaceuticals Daily , Hsbc Holdings , Management Inc , Free Report , Asset Management , Peabody Trust , Pharmaceuticals Stock Down , Get Free Report , Alnylam Pharmaceuticals Daily ,

Alnylam Pharmaceuticals (ALNY) to Release Earnings on Thursday

Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) is scheduled to issue its quarterly earnings data before the market opens on Thursday, May 2nd. Analysts expect the company to announce earnings of ($0.75) per share for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link. Alnylam […] ....

William Blair , Alnylam Pharmaceuticals , Earnings History For Alnylam Pharmaceuticals , Alnylam Pharmaceuticals Stock Down , News Ratings For Alnylam Pharmaceuticals Daily , Needham Company , Royal Bank , Alnylam Pharmaceuticals Company Profile , Morgan Stanley , Alnylam Pharmaceuticals Inc , Get Free Report , Pharmaceuticals Stock Down , Alnylam Pharmaceuticals Daily , Nasdaq Alny ,

William Blair Reaffirms Outperform Rating for Alnylam Pharmaceuticals (NASDAQ:ALNY)

William Blair reiterated their outperform rating on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a research report released on Monday, RTT News reports. ALNY has been the subject of several other reports. JPMorgan Chase & Co. boosted their target price on shares of Alnylam Pharmaceuticals from $150.00 to $170.00 and gave the company […] ....

William Blair , Jpmorgan Chase Co , Harbor Capital Advisors Inc , Analyst Recommendations For Alnylam Pharmaceuticals , Alnylam Pharmaceuticals Stock Down , News Ratings For Alnylam Pharmaceuticals Daily , Alnylam Pharmaceuticals , Ep Wealth Advisors , Steward Partners Investment Advisory , Alnylam Pharmaceuticals Inc , Wells Fargo Company , Morgan Stanley , Bridgewater Associates , Free Report , Moderate Buy , Pharmaceuticals Stock Down , Get Free Report , Capital Advisors , Financial Advisors , Partners Investment Advisory , Alnylam Pharmaceuticals Daily ,